Digital Self-Care could ease lymphatic pain after breast cancer
NCT ID NCT07701018
First seen Jul 14, 2026 · Last updated Jul 15, 2026 · Updated 1 time
Summary
This study tests a digital behavioral program called The-Optimal-Lymph-Flow (TOLF Self-Care) for breast cancer survivors who experience lymphatic pain—a common, often painful condition that can lead to chronic lymphedema. The program teaches self-care skills to promote lymph flow, aiming to reduce pain, swelling, and improve daily living. Researchers will implement the digital assessment and intervention in a clinical setting with 35 participants to see if it helps manage symptoms and prevent progression.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- The-Optimal-Lymph-Flow (TOLF Self-Care), a non-pharmacological digital behavioral intervention that teaches self-care skills to promote lymph flow and reduce pain and swelling.
- What this could lead to
- If effective, this digital self-care program could offer a simple, non-drug way to reduce lymphatic pain and prevent lymphedema from becoming chronic in breast cancer survivors.
- What could go wrong
- This is a small, early-stage adaptation study with only 35 participants, so results may not apply to all patients. The intervention relies on patient self-report and self-care, which may vary in effectiveness.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Missouri-Kansas City
Kansas City, Missouri, 64108, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Chest-Injected drug drain Cancer's fluid trap?
- A dab of gel on the breathing tube might spare surgery patients a sore throat — a trial puts it to the test.
- Can a deeper nerve block ease pain after breast surgery?
- Does breast cancer radiation harm a key immune gland? a study investigates
- A web program may ease the emotional toll of chemotherapy hair loss
- Can 3D breast imaging spot more dangerous cancers than standard mammograms?